niche industry
information & intelligence
on drug delivery logo

MAY 2011:
ORAL DRUG DELIVERY:
Formulation Selection Approaches & Novel Delivery Technologies

DOWNLOAD COMPLETE ISSUE: LO RES PDF (4.8 MB FILE)

DOWNLOAD COMPLETE ISSUE: HI RES PDF (9.9 MB FILE)

CONTENTS:

No Longer a Hit-or-Miss Proposition: Once-Daily Formulation for Drugs with pH-Dependent Solubility
Gopi Venkatesh, Director of R&D
Anthony Recupero, Senior Director, Business Development
Aptalis Pharmaceutical Technologies

ARTICLE PDF

A possible approach for the desire to innovate
Brian Wang, CEO & Dr Junsang Park, CSO
GL PharmTech

ARTICLE PDF

Company Profile:
Mayne Pharma International

ARTICLE PDF

From Powder to Pill: A Rational Approach to Formulating for First-into-Man Studies
Dr Robert Harris, Director, Early Development
Molecular Profiles Ltd

ARTICLE PDF

LiquiTime Oral Liquid Controlled Release Drug Delivery Platform
Camille Rivail, Business Development Analyst
Dr Jean Chatellier, Vice-President, Alliance Management
Flamel Technologies SA

ARTICLE PDF

Formulation Flexibility Broadens the Scope for Oral Thin Film Technology
Martha Sloboda, Business Manager
Dr Scott Barnhart, Technical Director
ARx LLC

ARTICLE PDF

Solumer™ Technology: a Viable Oral Dosage Form Option for BCS Class II Molecules
Dr Robert Lee, VP, Pharmaceutical Development, Particle Sciences Inc & Dr Amir Zalcenstein, CEO, Solubest Ltd
Particle Sciences Inc & Solubest Ltd

ARTICLE PDF

Controlled Drug Release: Novel Time-Delayed Formulations and their Clinical Evaluation
Dr Carol Thomson, COO
Drug Delivery International Ltd

ARTICLE PDF

Liquid-Fill Hard Two-Piece Capsules: The Answer to Many Product Development Issues
Mr Gary Norman, Product Development Manager
Encap Drug Delivery

ARTICLE PDF

Multi-Tip Tooling: A Guide
Dale Natoli, Vice-President
Natoli Engineering Company, Inc

ARTICLE PDF

DOWNLOAD COMPLETE ISSUE: LO RES PDF (4.8 MB FILE)

DOWNLOAD COMPLETE ISSUE: HI RES PDF (9.9 MB FILE)

Download the May Oral Drug Delivery Issue

click through to website